FDA advisers meet to decide next COVID-19 booster shot
COVID-19 boosters may be offered this fall, but first scientists need to determine what strains to target and who should receive the shots.
Jun 15, 2023
0
20
COVID-19 boosters may be offered this fall, but first scientists need to determine what strains to target and who should receive the shots.
Jun 15, 2023
0
20
After having successfully tested a mucosal vaccine against coronavirus in animals just months ago, Berlin scientists have now further developed their live SARS-CoV-2 vaccine. Researchers at Freie Universität Berlin have ...
Jun 13, 2023
0
100
The VLA1553 vaccine candidate for chikungunya disease was generally well tolerated and produced an immune response in 99% (263/266) of participants, according to a phase 3 randomized controlled trial published in The Lancet.
Jun 12, 2023
0
40
The winter months are synonymous with the flu in South Africa. Similar to other countries in the southern hemisphere, South Africa has an annual influenza season stretching from April to August.
Jun 9, 2023
0
2
A U.S. Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers.
Jun 9, 2023
0
2
The European Commission has followed the United States in approving the world's first vaccine for the Respiratory Syncytial Virus, to be used by adults aged 60 and over, its maker GlaxoSmithKline said Wednesday.
Jun 7, 2023
0
2
COVID-19 remains a threat even though it is no longer a global health emergency, the EU's vaccines watchdog warned on Tuesday in its final briefing of the pandemic.
Jun 6, 2023
0
0
A little-known respiratory virus is grabbing the limelight from COVID-19 and RSV after cases surged earlier this year, spurring companies to prepare their vaccines for a waiting market.
Jun 2, 2023
0
6
Cases of influenza (the flu) and COVID are set to rise over winter, with many Australians looking to protect themselves from both of these respiratory viruses.
Jun 2, 2023
0
11
The US drug regulator approved a second vaccine against respiratory syncytial virus (RSV), its American developer Pfizer said Wednesday, a month after the authorization of the first shot against the pathogen, a leading cause ...
Jun 1, 2023
0
2